| Sprycel (dasatinib) is an oral multi-BCR/ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML) who are no longer benefitting from or cannot tolerate prior treatment including Gleevec (imatinib mesylate), and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
Date added: June 10, 2011 | http://www.TreatmentForCML.com/ | Link visits: 11
|
|
|
» Subscribe
» Directory Statistics
1
0
592
107
105
Pending Links:
Links Today:
Active Links:
Featured Links:
Categories:
|